Terns Pharmaceuticals, Inc. (TERN)
NASDAQ: TERN · Real-Time Price · USD
2.880
+0.090 (3.23%)
At close: May 16, 2025, 4:00 PM
2.800
-0.080 (-2.78%)
After-hours: May 16, 2025, 7:53 PM EDT
Terns Pharmaceuticals Market Cap
Terns Pharmaceuticals has a market cap or net worth of $251.53 million as of May 16, 2025. Its market cap has decreased by -23.44% in one year.
Market Cap
251.53M
Enterprise Value
-81.50M
1-Year Change
-23.44%
Ranking
Category
Stock Price
$2.88
Market Cap Chart
Since the IPO on February 5, 2021, Terns Pharmaceuticals's market cap has increased from $143.61M to $251.53M, an increase of 75.15%. That is a compound annual growth rate of 14.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 16, 2025 | 251.53M | -46.55% |
| Dec 31, 2024 | 470.56M | 17.33% |
| Dec 29, 2023 | 401.05M | -20.44% |
| Dec 30, 2022 | 504.08M | 182.17% |
| Dec 31, 2021 | 178.64M | 24.39% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 677.51B |
| Johnson & Johnson | 363.91B |
| AbbVie | 322.97B |
| Novo Nordisk | 282.81B |
| UnitedHealth Group | 259.58B |
| Abbott Laboratories | 234.65B |
| Novartis AG | 211.47B |
| AstraZeneca | 208.86B |